Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4GV1

PKB alpha in complex with AZD5363

Summary for 4GV1
Entry DOI10.2210/pdb4gv1/pdb
DescriptorRAC-alpha serine/threonine-protein kinase, 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide, GLYCEROL, ... (4 entities in total)
Functional Keywordsprotein kinase, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceHomo sapiens (human)
Cellular locationCytoplasm: P31749
Total number of polymer chains1
Total formula weight40191.15
Authors
Primary citationAddie, M.,Ballard, P.,Buttar, D.,Crafter, C.,Currie, G.,Davies, B.R.,Debreczeni, J.,Dry, H.,Dudley, P.,Greenwood, R.,Johnson, P.D.,Kettle, J.G.,Lane, C.,Lamont, G.,Leach, A.,Luke, R.W.,Morris, J.,Ogilvie, D.,Page, K.,Pass, M.,Pearson, S.,Ruston, L.
Discovery of 4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an Orally Bioavailable, Potent Inhibitor of Akt Kinases.
J.Med.Chem., 56:2059-2073, 2013
Cited by
PubMed Abstract: Wide-ranging exploration of analogues of an ATP-competitive pyrrolopyrimidine inhibitor of Akt led to the discovery of clinical candidate AZD5363, which showed increased potency, reduced hERG affinity, and higher selectivity against the closely related AGC kinase ROCK. This compound demonstrated good preclinical drug metabolism and pharmacokinetics (DMPK) properties and, after oral dosing, showed pharmacodynamic knockdown of phosphorylation of Akt and downstream biomarkers in vivo, and inhibition of tumor growth in a breast cancer xenograft model.
PubMed: 23394218
DOI: 10.1021/jm301762v
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.49 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon